Tracon Pharmaceuticals Inc (TCON)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0322 -0.0113 (-25.98%) 12/02/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0322 unch (unch) -
for Mon, Dec 2nd, 2024
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 55 | 100 | 3,045 | 0 | 9,000 |
Gross Profit | 55 | 100 | 3,045 | N/A | 9,000 |
Operating Expenses | 2,967 | 3,312 | 2,638 | 1,588 | 9,779 |
Operating Income | -2,912 | -3,212 | 407 | -1,588 | -779 |
Interest Expense | -75 | -53 | -37 | 646 | 5,507 |
Other Income | -2 | -9 | -5 | 12,997 | 0 |
Pre-tax Income | -2,839 | -3,168 | 439 | 10,763 | -6,286 |
Net Income Continuous | -2,839 | -3,168 | 439 | 10,763 | -6,286 |
Net Income | $-2,839 | $-3,168 | $439 | $10,763 | $-6,286 |
EPS Basic Total Ops | -0.94 | -1.33 | 2.70 | 5.80 | -3.94 |
EPS Basic Continuous Ops | -0.94 | -1.33 | 2.65 | 5.85 | -3.94 |
EPS Diluted Total Ops | -0.94 | -1.33 | 2.70 | 5.80 | -3.94 |
EPS Diluted Continuous Ops | -0.94 | -1.33 | 2.67 | 5.84 | -3.94 |
EPS Diluted Before Non-Recurring Items | -0.94 | -1.33 | 0.20 | 5.80 | -1.20 |
EBITDA(a) | $-2,908 | $-3,204 | $414 | $-911 | $4,762 |